Regional differences in incidence and patient characteristics of moyamoya disease: A systematic review

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 5, 2012, Pages 531-536

  Kleinloog, Rachel ^a   Regli, Luca ^a   Rinkel, Gabriel J E ^a   Klijn, Catharina J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CHINA; CINAHL; CLINICAL FEATURE; EMBASE; ETHNIC DIFFERENCE; FAMILY HISTORY; FATALITY; GEOGRAPHIC DISTRIBUTION; HUMAN; JAPAN; MEDLINE; MORBIDITY; MOYAMOYA DISEASE; ONSET AGE; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SEX RATIO; SYSTEMATIC REVIEW; TAIWAN; UNITED STATES;

EID: 84859714554     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2011-301387     Document Type: Review

References (32)

1. Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288-99.
2. Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol 2008;7:1056-66.
3. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med 2009;360:1226-37.
4. Wakai K, Tamakoshi A, Ikezaki K, et al. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg 1997;99 (Suppl 2):S1-5. (Pubitemid 27489053)
5. Kuriyama S, Kusaka Y, Fujimura M, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 2008;39:42-7.
6. Goto Y, Yonekawa Y. Worldwide distribution of moyamoya disease. Neurol Med Chir (Tokyo) 1992;32:883-6. (Pubitemid 23009644)
7. Suzuki J, Kodama N. Moyamoya disease - a review. Stroke 1983;14:104-9.
8. Han DH, Kwon OK, Byun BJ, et al. A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). the Korean Society for cerebrovascular disease. Acta Neurochir (Wien) 2000;142:1263-73.
9. Chiu D, Shedden P, Bratina P, et al. Clinical features of moyamoya disease in the United States. Stroke 1998;29:1347-51. (Pubitemid 28300068)
10. Yilmaz EY, Pritz MB, Bruno A, et al. Moyamoya: Indiana University Medical Center experience. Arch Neurol 2001;58:1274-8. (Pubitemid 32751747)
11. Hallemeier CL, Rich KM, Grubb RL Jr, et al. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 2006;37:1490-6. (Pubitemid 44305731)
12. Kraemer M, Heienbrok W, Berlit P. Moyamoya disease in Europeans. Stroke 2008;39:3193-200.
13. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Clin Neurol Neurosurg 1997;99:S238-40. (Pubitemid 27489104)
14. Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 2008;79:900-4.
15. Hung CC, Tu YK, Su CF, et al. Epidemiological study of moyamoya disease in Taiwan. Clin Neurol Neurosurg 1997;99(Suppl 2):S23-5.
16. Miao W, Zhao PL, Zhang YS, et al. Epidemiological and clinical features of moyamoya disease in Nanjing, China. Clin Neurol Neurosurg 2010;112:199-203.
17. Uchino K, Johnston SC, Becker KJ, et al. Moyamoya disease in Washington state and California. Neurology 2005;65:956-8. (Pubitemid 41362154)
18. Wetjen NM, Garell PC, Stence NV, et al. Moyamoya disease in the midwestern United States. Neurosurg Focus 1998;5:e1.
19. Graham JF, Matoba A. A survey of moyamoya disease in Hawaii. Clin Neurol Neurosurg 1997;99(Suppl 2):S31-5. (Pubitemid 27489059)
20. Yonekawa Y, Handa H, Okuno T. Moyamoya disease: diagnosis, treatment and recent achievements. Stroke 1986;1:805-29.
21. Yonekawa Y, Ogata N, Kaku Y, et al. Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg 1997;99(Suppl 2):S58-60. (Pubitemid 27489065)
22. Yonekawa Y. Moyamoya angiopathy in Europe. In: Cho BK, Tominaga T, eds. Moyamoya disease update. Tokyo: Springer, 2010:361-9.
23. Scott RM, Smith JL, Robertson RL, et al. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 2004;100:142-9. (Pubitemid 38141339)
24. Fukui M. Current state of study on moyamoya disease in Japan. Surg Neurol 1997;47:138-43. (Pubitemid 27074166)
25. Roder C, Nayak NR, Khan N, et al. Genetics of moyamoya disease. J Hum Genet 2010;55:711-16.
26. Kamada F, Aoki Y, Narisawa A, et al. A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet 2011;56:34-40.
27. Guo DC, Papke CL, Tran-Fadulu V, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and moyamoya disease, along with thoracic aortic disease. Am J Hum Genet 2009;84:617-27.
28. Roder C, Peters V, Kasuya H, et al. Analysis of ACTA2 in European moyamoya disease patients. Eur J Paediatr Neurol 2011;15:117-22.
29. Roder C, Peters V, Kasuya H, et al. Common genetic polymorphisms in moyamoya and atherosclerotic disease in Europeans. Childs Nerv Syst 2011;27:245-52.
30. Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007;357:443-53. (Pubitemid 47204873)
31. Roder C, Peters V, Kasuya H, et al. Polymorphisms in TGFB1 and PDGFRB are associated with moyamoya disease in European patients. Acta Neurochir (Wien) 2010;152:2153-60.
32. Krischek B, Kasuya H, Khan N, et al. Genetic and clinical characteristics of moyamoya disease in Europeans. Acta Neurochir Suppl 2011;112:31-4.